Surefire Medical, Inc. Scores $18.2 Million Series B

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WESTMINSTER, Colo.--(BUSINESS WIRE)--Surefire Medical, Inc. a commercial stage medical device company developing innovative infusion systems for minimally invasive, direct-to-target interventional procedures, announced today that it has completed a $18.2 million Series B funding. The latest financing will be used to expand product development, clinical trials, operations and marketing to meet rapidly growing national and international customer demand.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC